RNA Supply Chain Solutions
-
GenVoy-ILM™ T Cell Kit For mRNA, Ignite™
7/1/2022
GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.
-
Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT
3/13/2025
Having produced over 185,000 DNA lots, including 5,000+ cGMP batches, we are a trusted partner in plasmid DNA production from discovery to commercialization.
-
Prima Product Line Up
3/17/2026
Discover how specialized RNA polymerase variants solve yield, purity, and capping challenges across different template lengths, with substantive improvements over standard T7 polymerase performance.
-
Mitigate Contamination Risks With HTST Flash Pasteurization
5/2/2024
Gibco™ High-temperature, short-time (HTST) treatment of raw materials
HTST treatment currently available in North America
Simple sugar batch sizes ranging from 800 to 8,800 L
In-house HTST preparation can be expensive and cumbersome. Outsourcing this technology to Thermo Fisher Scientific can alleviate production bottlenecks and increase viral mitigation confidence.
Suitable and cost-effective for large volumes
Standard and custom bioprocessing containers available (5 L–1,000 L). Please contact your sales representative.
-
Plasmid DNA Manufacturing
1/31/2023
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.
-
Excellence For Cell And Gene Therapy Manufacturing
6/4/2025
Unlock the potential of advanced therapies with dedicated partnership and tailored manufacturing solutions, ensuring quality and efficiency from discovery through to delivery for next-generation treatments.
-
Synthetic Research Grade sgRNA Manufacturing For CRISPR Experiments
11/28/2023
Consistently achieve high editing efficiency and quick turnaround time in as little as 7 days with synthetic sgRNA that pave your way to a successful CRISPR experiment.
-
Plasmid DNA Production
6/23/2022
Integrated manufacturing supporting cell and gene therapies.
The critical genetic foundation for advanced therapies
Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.
-
The Most Comprehensive Supply Chain Solutions For The Life Sciences Industry
1/5/2022
Cryoport has expanded beyond just temperature-controlled logistics — it’s now the premier provider of supply chain solutions for life sciences, supporting research, clinical trials, commercial cell therapies around the world.
-
Vaccinia Capping System For mRNA Therapeutics
12/5/2025
Backed by over a decade of expertise in capping enzyme production, this system is a robust, scalable solution designed to support production journeys from early R&D to full-scale manufacturing.